Immucell Announces Leadership Transition and Strategic Plans

Pick the best stocks and maximize your portfolio:

Immucell ( (ICCC) ) has shared an announcement.

ImmuCell Corporation has signed an Employment and Separation Agreement with Elizabeth L. Williams, its VP of Manufacturing Operations, effective until her retirement on July 1, 2025. Williams will continue part-time and transition her duties, with a potential $100,000 bonus if she meets the agreement terms. This step is part of a strategic transition plan for the company’s leadership.

For a thorough assessment of ICCC stock, go to TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.